Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for BSEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 17.82M
March 31, 2026 16.97M
December 31, 2025 16.81M
September 30, 2025 16.77M
June 30, 2025 16.73M
March 31, 2025 16.71M
December 31, 2024 16.64M
September 30, 2024 16.32M
June 30, 2024 16.27M
March 31, 2024 16.33M
December 31, 2023 16.20M
September 30, 2023 13.10M
June 30, 2023 13.47M
March 31, 2023 13.10M
December 31, 2022 12.14M
September 30, 2022 12.12M
June 30, 2022 11.70M
March 31, 2022 9.681M
December 31, 2021 9.744M
September 30, 2021 9.26M
June 30, 2021 9.347M
Date Value
March 31, 2021 9.241M
December 31, 2020 9.204M
September 30, 2020 9.165M
June 30, 2020 9.045M
March 31, 2020 9.145M
June 30, 2019 9.135M
March 31, 2019
December 31, 2018 9.135M
September 30, 2018 8.666M
June 30, 2018 7.657M
March 31, 2018 7.513M
December 31, 2017 7.269M
September 30, 2017 6.618M
June 30, 2017 3.402M
March 31, 2017 3.640M
December 31, 2016 3.635M
September 30, 2016 3.800M
June 30, 2016 3.674M
March 31, 2016 3.135M
June 30, 2014 0.9612M
March 31, 2014 0.8612M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 48.31M
CorMedix, Inc. 77.67M
Eloxx Pharmaceuticals, Inc. 4.036M
Cannabis Global, Inc. 6.564B
Breakthrough Chemistry, Inc. 9.729M